Target intelligence / Profile preview

Novel transcript, sense intronic to RP11-654K19.6 (ENSG00000289233)

Target: ENSG00000289233
Molecular classification: Long non-coding RNA (lncRNA), sense-intronic lncRNA

Overview

This molecule is a long non-coding RNA (lncRNA) classified as a sense-intronic transcript, meaning it is located within an intron of another gene but on the same strand, without overlapping any exons[1]. Its annotation is based on sequence data and transcript structure, not on evidence of protein-coding function or therapeutic relevance. The RP11-654K19.6 nomenclature refers to a BAC clone identifier, not a functional name. There is currently no information in the literature describing biological functions, disease relevance, drug interactions, or utility as a biomarker. In general, similar sense-intronic lncRNAs may participate in gene regulation at the RNA level, but specific roles for this transcript have not been shown[1][3].

Other names: RP11-654K19.6 (clone-based locus designation)ENSG00000289233 (Ensembl gene ID)

Mechanism of action

Null; no therapies or drugs target this transcript, so no mechanism of action applies.

Biological functions

Unknown. Generally, sense-intronic lncRNAs are thought to play roles in regulation of gene expression, but specific functions for this transcript are not described

Disease associations

None known; no experimental or clinical evidence links this transcript to any disease as of this writing

Safety considerations

Null; there are no therapeutic interventions, so no safety concerns are relevant.

Interacting drugs

None; there are no drugs reported or known to interact with this transcript.

Biomarkers

None; this transcript is not established as a biomarker for patient selection or monitoring

Beyond the preview

Go deeper on Novel transcript, sense intronic to RP11-654K19.6 (ENSG00000289233).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, sense intronic to RP11-654K19.6 (ENSG00000289233).

Explore the full profile